Security Snapshot

ISHARES TR - MSCI GBL SUS DEV (SDG) Institutional Ownership

CUSIP: 46435G532

13F Institutional Holders and Ownership History from Q2 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

102

Shares (Excl. Options)

769,553

Price

$84.22

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / MSCI GBL SUS DEV
Symbol
SDG
Price per share
$84.75
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
769,553
Total reported value
$64,837,957
% of total 13F portfolios
0%
Share change
-64,889
Value change
-$5,474,489
Number of holders
102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SDG - ISHARES TR - MSCI GBL SUS DEV is tracked under CUSIP 46435G532.
  • 102 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 102 to 61 between Q4 2025 and Q1 2026.
  • Reported value moved from $64,837,957 to $24,626,857.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 102 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 46435G532?
CUSIP 46435G532 identifies SDG - ISHARES TR - MSCI GBL SUS DEV in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 102 institutional investors reported holding 769,553 shares of ISHARES TR - MSCI GBL SUS DEV (SDG).

Institutional Holders of ISHARES TR - MSCI GBL SUS DEV (SDG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 292,556 $24,626,857 -$22,759 $83.95 61
2025 Q4 769,553 $64,837,957 -$5,474,489 $84.22 102
2025 Q3 834,299 $69,374,083 -$1,087,818 $83.20 99
2025 Q2 856,964 $65,043,985 -$7,522,509 $75.86 96
2025 Q1 958,851 $69,459,837 -$16,799,451 $72.39 108
2024 Q4 1,197,516 $85,818,933 -$5,499,877 $71.56 111
2024 Q3 1,294,186 $109,580,378 -$12,798,701 $84.79 119
2024 Q2 1,449,422 $108,893,184 -$21,795,065 $75.07 115
2024 Q1 1,740,304 $137,026,492 -$10,712,865 $78.71 115
2023 Q4 1,875,298 $151,885,118 +$328,228 $81.05 123
2023 Q3 1,871,997 $139,439,318 -$1,652,602 $74.52 115
2023 Q2 1,887,372 $149,165,806 -$7,405,253 $79.05 114
2023 Q1 1,994,485 $157,942,009 +$10,076,868 $79.19 122
2022 Q4 1,865,872 $147,363,725 +$7,890,021 $78.91 125
2022 Q3 1,764,337 $125,320,736 +$13,110,657 $70.87 108
2022 Q2 1,576,624 $125,968,061 -$24,616,281 $79.88 107
2022 Q1 1,878,989 $160,408,429 -$33,625,508 $85.30 114
2021 Q4 2,276,157 $206,552,012 +$27,282,485 $90.76 124
2021 Q3 1,317,948 $126,549,728 +$19,552,374 $96.06 115
2021 Q2 1,718,704 $170,796,479 +$9,481,043 $99.37 111
2021 Q1 1,672,509 $161,797,542 +$16,303,606 $94.84 98
2020 Q4 1,498,500 $143,766,064 +$18,558,496 $93.35 83
2020 Q3 596,421 $47,959,332 +$5,016,876 $80.47 56
2020 Q2 534,757 $36,445,706 +$7,762,512 $68.16 40
2020 Q1 421,092 $24,222,037 +$5,659,805 $57.47 33
2019 Q4 322,851 $21,129,761 +$2,710,984 $65.44 37
2019 Q3 287,977 $16,808,802 +$2,444,950 $58.38 31
2019 Q2 248,678 $14,346,417 +$4,936,668 $57.68 31
2019 Q1 162,905 $9,608,583 +$972,253 $59.00 30
2018 Q4 181,733 $9,644,672 +$1,587,005 $53.00 29
2018 Q3 149,039 $8,689,033 -$1,992,957 $58.30 28
2018 Q2 183,353 $10,427,121 -$1,036,404 $56.67 26
2018 Q1 200,668 $11,811,642 +$6,649,089 $58.88 24
2017 Q4 127,696 $7,558,632 -$1,607,129 $59.18 20
2017 Q3 151,375 $8,766,709 -$2,405,146 $57.91 18
2017 Q2 192,915 $10,707,815 -$2,037,009 $55.50 11
2017 Q1 232,008 $11,929,000 +$1,404,774 $51.39 7
2016 Q4 204,711 $9,769,000 -$3,110,289 $47.72 7
2016 Q3 269,858 $13,499,000 -$1,345,920 $50.04 8
2016 Q2 297,015 $14,174,000 +$14,174,000 $47.72 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .